The Discounted Cash Flow (DCF) valuation of CellaVision AB (CEVI.ST) is 196.48 SEK. With the latest stock price at 152.00 SEK, the upside of CellaVision AB based on DCF is 29.3%.
Based on the latest price of 152.00 SEK and our DCF valuation, CellaVision AB (CEVI.ST) is a buy. buying CEVI.ST stocks now will result in a potential gain of 29.3%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 8.0% | 6.4% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 119.12 - 757.00 | 196.48 |
| Upside | -21.6% - 398.0% | 29.3% |